These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1119 related items for PubMed ID: 19808337
1. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure. Magrì D, Brioschi M, Banfi C, Schmid JP, Palermo P, Contini M, Apostolo A, Bussotti M, Tremoli E, Sciomer S, Cattadori G, Fiorentini C, Agostoni P. Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337 [Abstract] [Full Text] [Related]
2. Sildenafil improves the alveolar-capillary function in heart failure patients. Bussotti M, Montorsi P, Amato M, Magini A, Baldassarre D, Tantardini F, Veglia F, Agostoni P. Int J Cardiol; 2008 May 07; 126(1):68-72. PubMed ID: 17490765 [Abstract] [Full Text] [Related]
3. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD, Gruppo di Studio Fisiologia dell'Esercizio, Cardiologia dello Sport e Riabilitazione Cardiovascolare of the Italian Society of Cardiology. Am Heart J; 2007 May 07; 153(5):859-67. PubMed ID: 17452165 [Abstract] [Full Text] [Related]
4. Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure. Ingle L, Goode K, Carroll S, Sloan R, Boyes C, Cleland JG, Clark AL. Int J Cardiol; 2007 Jun 12; 118(3):350-5. PubMed ID: 17067694 [Abstract] [Full Text] [Related]
11. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi MD. J Am Coll Cardiol; 2004 Dec 21; 44(12):2339-48. PubMed ID: 15607396 [Abstract] [Full Text] [Related]
13. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity]. Guazzi M, Lauri G, Melzi G, Cattadori G, Agostoni P. Cardiologia; 1996 Jun 21; 41(6):527-33. PubMed ID: 8766415 [Abstract] [Full Text] [Related]
14. Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure. Arena R, Humphrey R, Peberdy MA. Eur J Cardiovasc Prev Rehabil; 2003 Dec 21; 10(6):463-8. PubMed ID: 14671470 [Abstract] [Full Text] [Related]